Top Story

Despite clinical success, laparoscopic colectomy underused in colon cancer treatment

March 5, 2015

Laparoscopic colectomy has shown superiority in clinical trials to open colectomy, but most physicians still choose open resection as the standard of surgical care for colon cancer, according to study results.

Many randomized clinical trials in the past decade have shown patients who undergo laparoscopic colectomies experience better short-term outcomes than those who undergo open colectomy. These benefits include better 30-day mortality, fewer unplanned readmissions and shorter lengths of stay.

SCOTUS hears arguments over tax credits for subsidies under ACA

March 4, 2015
The U.S. Supreme Court today began hearing oral arguments in King vs. Burwell, a case that will determine whether the Internal Revenue Service may extend tax-credit…

Bortezomib-based therapy improves outcomes, increases toxicity in mantle cell lymphoma

March 4, 2015
The substitution of bortezomib for vincristine in front-line therapy for mantle cell lymphoma was associated with prolonged PFS and higher response rates, according to…
Meeting News Coverage

Common goals, barriers to antimicrobial stewardship among pediatric cancer patients identified

March 4, 2015
MEMPHIS, Tenn. — Doctors and pharmacists involved in antimicrobial stewardship programs among pediatric cancer patients identified shared program-related goals as…
FDA approvals

FDA expands approval of Opdivo for advanced squamous NSCLC

March 4, 2015
The FDA today expanded the existing indication of nivolumab to include patients with metastatic squamous non–small cell lung cancer with progression on or after…
More News Headlines »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »